| |
> Therapeutics
 > Agriculture
|
|
We presently license our technology on a crop-by-crop basis to agricultural companies capable of incorporating our technology into crops grown for commercial agriculture. We anticipate revenues from these relationships in the form of:
• Licensing fees
• Research and development benchmarks
• Royalties from enhanced crops
This commercialization strategy allows us to generate revenues at various stages of product development, while ensuring that our technology is incorporated into a wide variety of crops. Our optimal partners combine the technological know-how to incorporate our technology into their product line along with the ability to successfully market the enhanced final product.
We have established relationships with:
|
